… and clinical trials geared at combating motoneuron and cognitive disorders and
discussing what is known about the way in which these various interventions modulate TDP-43. …

… of therapy of patients suffering from Parkinson's disease. … caused an increase in the
concentration of growth hormone in … Studies have shown that berberine modulates the activity of …

PD is a progressive neurodegenerative disease that results in intolerable disability for most
patients despite the best current medical and surgical therapies. A treatment that slows, or …

… ” Parkinson disease (PD) could be a big problem for patients. … , and a good reaction to
levodopa substances. The diagnosis … be an important contributing factor to modulate the long-term …

… Gut microbiota metabolites can also act on targets of host that are near or distant from
gastrointestinal tract to directly modulate the functions of hosts. For example, upon their release …

… secretion of endogenous opioids in the brain was the key event in placebo pain
modulation. … 1B/1D receptors that stimulates growth hormone (GH) and inhibits cortisol (glucocorticoids) …

Depression is among the most common symptoms of Parkinson’s disease (PD); and its
estimated prevalence is 35%. A systematic review revealed that there is insufficient evidence to …

… have long been recognized to contribute to Parkinson's disease (PD), a common movement
… its Neh6 domain, one of which can be modulated by glycogen synthase kinase 3β (GSK-3β) …

Parkinson’s disease (PD) is characterized by the loss of dopaminergic neurons in the
substantia nigra pars compacta. Oxidative stress, mitochondrial dysfunction, inflammation and …